“Our findings and existing clinical literature imply that patients respond to medical marijuana legislation as if there are clinical benefits to the drug, which adds to the growing body of evidence suggesting that the Schedule 1 status of marijuana is outdated,” the study concludes.”
Related Posts
Cannabis induces a clinical response in patients with Crohn’s disease: a prospective placebo-controlled study (2013)
- WOCredentials
- September 19, 2016
- 0
“a short course (8 weeks) of THC-rich cannabis produced significant clinical, steroid-free benefits to 10 of 11 patients with active Crohn’s disease, compared with placebo, without side effects.” Naftali, T., […]
Does access to medical marijuana reduce opioid deaths?
- WOCredentials
- September 15, 2016
- 0
“The three studies ‘tell a similar story,’ said Pacula: After medical marijuana comes to a state, ‘fewer people are dying’ of opioid overdoses. ‘If it were just one study, or […]
Cannabinoids remove plaque-forming Alzheimer’s proteins
- WOCredentials
- July 19, 2016
- 0
“Salk Institute scientists have found preliminary evidence that tetrahydrocannabinol (THC) and other compounds found in marijuana can promote the cellular removal of amyloid beta, a toxic protein associated with Alzheimer’s […]